Read + Share
Yamasaki K, Yamanaka K, Zhao Y, Iwano S, et al. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final
analysis of a 52-week phase 3 open-label study. J Dermatol 2022;49:479-487.
PMID: 35243682
|
 |
|
Yamasaki K, Yamanaka K, Zhao Y, Iwano S, et al. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final
analysis of a 52-week phase 3 open-label study. J Dermatol 2022;49:479-487.
PMID: 35243682
|
|
|
|